B Salassa

703 total citations
17 papers, 413 citations indexed

About

B Salassa is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, B Salassa has authored 17 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Virology. Recurrent topics in B Salassa's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). B Salassa is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). B Salassa collaborates with scholars based in Italy, United States and Switzerland. B Salassa's co-authors include Alessandro Sinicco, Giovanni Rezza, Patrizio Pezzotti, F Aiuti, L Ortona, Maria Dorrucci, R. Pristerà, Mauro Sciandra, R Zerboni and P Gioannini and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

B Salassa

17 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Salassa Italy 10 258 231 137 114 72 17 413
Cristina Mussini Italy 11 336 1.3× 184 0.8× 47 0.3× 229 2.0× 47 0.7× 27 484
Suzanne Fiorillo United States 11 137 0.5× 110 0.5× 123 0.9× 58 0.5× 20 0.3× 19 386
Ana Barrios Spain 10 243 0.9× 65 0.3× 69 0.5× 194 1.7× 12 0.2× 19 371
L Caggese Italy 8 461 1.8× 150 0.6× 29 0.2× 318 2.8× 25 0.3× 9 597
Bernd S. Kamps Germany 4 239 0.9× 168 0.7× 71 0.5× 171 1.5× 4 0.1× 8 374
Dubravka Salemović Serbia 10 191 0.7× 179 0.8× 15 0.1× 145 1.3× 27 0.4× 41 379
María Jesús Vivancos Spain 12 166 0.6× 121 0.5× 23 0.2× 87 0.8× 38 0.5× 54 300
G. Carosi Italy 9 123 0.5× 63 0.3× 91 0.7× 64 0.6× 16 0.2× 22 254
Paola Corsi Italy 14 353 1.4× 106 0.5× 30 0.2× 321 2.8× 16 0.2× 30 448
Barry Schmetter United States 10 532 2.1× 137 0.6× 27 0.2× 398 3.5× 53 0.7× 10 718

Countries citing papers authored by B Salassa

Since Specialization
Citations

This map shows the geographic impact of B Salassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Salassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Salassa more than expected).

Fields of papers citing papers by B Salassa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Salassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Salassa. The network helps show where B Salassa may publish in the future.

Co-authorship network of co-authors of B Salassa

This figure shows the co-authorship network connecting the top 25 collaborators of B Salassa. A scholar is included among the top collaborators of B Salassa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Salassa. B Salassa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Marinaro, Letizia, Andrea Calcagno, Diego Ripamonti, et al.. (2016). Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. Journal of Clinical Virology. 87. 30–36. 4 indexed citations
2.
Calcagno, Andrea, Ilaria Motta, Valeria Ghisetti, et al.. (2015). HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. AIDS Research and Human Retroviruses. 31(10). 999–1008. 18 indexed citations
3.
Calcagno, Andrea, Daniel González de Requena, Marco Simiele, et al.. (2013). Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-Sectional Study of HIV-Positive Patients with Normal Renal Function. Antimicrobial Agents and Chemotherapy. 57(4). 1840–1843. 41 indexed citations
4.
Girardi, Enrico, G. Antonucci, Fabrizio Palmieri, et al.. (2004). Tuberculosis in HIV‐infected persons in the context of wide availability of highly active antiretroviral therapy. European Respiratory Journal. 24(1). 11–17. 43 indexed citations
5.
Pezzotti, Patrizio, Maria Dorrucci, Alessandra Donisi, et al.. (2004). [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].. PubMed. 27(6). 348–55. 12 indexed citations
6.
Rezza, Giovanni, Maria Dorrucci, Diego Serraino, et al.. (2000). Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. AIDS. 14(11). 1647–1653. 27 indexed citations
7.
Rezza, Giovanni, Massimo Andreoni, Maria Dorrucci, et al.. (1999). Human Herpesvirus 8 Seropositivity and Risk of Kaposi's Sarcoma and Other Acquired Immunodeficiency Syndrome-Related Diseases. JNCI Journal of the National Cancer Institute. 91(17). 1468–1474. 105 indexed citations
8.
Dorrucci, Maria, Giovanni Rezza, Massimo Andreoni, et al.. (1999). Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. European Journal of Epidemiology. 15(4). 317–322. 4 indexed citations
9.
Sinicco, Alessandro, et al.. (1997). Coinfection and Superinfection of Hepatitis B Virus in Patients Infected with Human Immunodeficiency Virus: No Evidence of Faster Progression to AIDS. Scandinavian Journal of Infectious Diseases. 29(2). 111–115. 61 indexed citations
10.
Tibaldi, Cecilia, Pier‐Angelo Tovo, Elvia Palomba, et al.. (1993). Asymptomatic women at high risk of vertical HIV‐1 transmission to their fetuses. BJOG An International Journal of Obstetrics & Gynaecology. 100(4). 334–337. 14 indexed citations
11.
Salassa, B, Ferruccio Bonino, C Lavarini, et al.. (1991). Serological diagnosis of hepatitis B and delta virus (HBV/HDV) coinfection. Journal of Hepatology. 12(1). 10–13. 9 indexed citations
12.
Rezza, Giovanni, Adriano Lazzarin, Gioacchino Angarano, et al.. (1990). Risk of AIDS in HIV seroconverters: A comparison between intravenous drug users and homosexual males. European Journal of Epidemiology. 6(1). 99–101. 16 indexed citations
13.
Rezza, Giovanni, Adriano Lazzarin, Gioacchino Angarano, et al.. (1989). The natural history of HIV infection in intravenous drug users. AIDS. 3(2). 87–90. 50 indexed citations
14.
Salassa, B, et al.. (1987). [Hospital infections in an emergency surgery ward].. PubMed. 78(18). 1363–70. 1 indexed citations
15.
Andreoni, Giuseppe, et al.. (1986). [Cephalosporins and enzymuria].. PubMed. 77(7-8). 231–7. 5 indexed citations
16.
Salassa, B, et al.. (1982). [Use of arginine thiazolidine carboxylate in the treatment of chronic hepatitis. Preliminary findings].. PubMed. 28(1). 65–70. 2 indexed citations
17.
Airoldi, Mario, et al.. (1980). [Evaluation of some nonspecific immunological parameters in patients with oral cavity carcinoma undergoing cryosurgery].. PubMed. 56(13). 1334–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026